ArticleHospital pharmacy2021

Retrospective Analysis of Clinical Outcomes Associated With the Use of Pegfilgrastim On-body Injector in Patients Receiving Chemotherapy Requiring Granulocyte Colony-Stimulating Factor Support.

Jolly Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.